Published in Am J Med on August 01, 1995
Poor prognosis of patients presenting with symptomatic myocardial infarction but without chest pain. Heart (2001) 0.96
Recognising "painless" heart attacks. Heart (2002) 0.81
Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med (1995) 3.32
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. Arch Intern Med (2000) 2.27
Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: a randomized trial. Gastroenterology (1999) 1.91
Effectiveness and patient satisfaction with screening flexible sigmoidoscopy performed by registered nurses. Gastrointest Endosc (1999) 1.89
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. Circulation (1994) 1.57
Bedside blood glucose determinations in critical care medicine: a comparative analysis of two techniques. Crit Care Med (1982) 1.46
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care (1999) 1.43
Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group. Circulation (1996) 1.37
Four-Year persistence patterns among patients initiating therapy with the angiotensin II receptor antagonist losartan versus other artihypertensive drug classes. Clin Ther (2001) 1.33
Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol (1999) 1.21
Training of providers in embryo transfer: what is the minimum number of transfers required for proficiency? Hum Reprod (2001) 1.14
Randomized, cross-over, controlled comparison of two inactivated hepatitis A vaccines. Vaccine (2000) 1.11
Reductions in herpes simplex virus type 2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV-positive men. Psychosom Med (2001) 1.04
Can cardiovascular clinical characteristics be identified and outcome models be developed from an in-patient claims database? Am J Cardiol (1999) 1.00
Effect of an evidence-based medicine seminar on participants' interpretations of clinical trials: a pilot study. Acad Med (2000) 1.00
Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis (2001) 0.99
Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group. N Engl J Med (1994) 0.92
Marked reduction in long-term cardiac deaths with aspirin after a coronary event. Multicenter Myocardial Ischemia Research Group. J Am Coll Cardiol (1996) 0.87
Multiple-dose vials: persistence of bacterial contaminants and infection control implications. Infect Control (1985) 0.86
Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty. The Lovastatin Restenosis Trial Study Group. Am J Cardiol (1992) 0.86
Risk factors for hospitalizations resulting from pulmonary embolism after renal transplantation in the United States. J Nephrol (2001) 0.85
Hospitalized valvular heart disease in patients on renal transplant waiting list: incidence, clinical correlates and outcomes. Clin Nephrol (2003) 0.85
Measurement of perceived disruption during rebuilding following Hurricane Andrew. J Trauma Stress (1997) 0.83
Plasma, urine, and CSF catecholamine concentrations during and after ketamine anesthesia. Crit Care Med (1982) 0.83
Peripheral serotonin levels in women: role of aging and ethnicity. Gerontology (1998) 0.82
Effects of cholesterol lowering on the progression of coronary atherosclerosis in women. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) substudy. Circulation (1995) 0.82
Double-blind, placebo-controlled, crossover trial of propranolol as treatment for menopausal vasomotor symptoms. Clin Ther (1981) 0.82
The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes. J Nephrol (2001) 0.81
Performance assessment model for guideline-recommended pharmacotherapy in the secondary prevention of coronary artery disease and treatment of left ventricular dysfunction. Am J Cardiol (1997) 0.81
The effect of propranolol on catecholamine clearance. Clin Pharmacol Ther (1986) 0.79
The effect of decreasing digital image resolution on teledermatology diagnosis. Telemed J (1999) 0.79
Early normalization of platelet survival by endothelial seeding of Dacron arterial prostheses in dogs. Surgery (1982) 0.79
Hospitalizations for fungal infections after initiation of chronic dialysis in the United States. Nephron (2001) 0.77
Economic impact of GPIIB/IIIA blockade after high-risk angioplasty: results from the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis. J Am Coll Cardiol (1999) 0.76
Serial acquisition of data to predict one-year mortality rate after acute myocardial infarction. Am J Cardiol (1987) 0.76
Targeting patients undergoing angioplasty for thrombus inhibition: a cost-effectiveness and decision support model. Circulation (2000) 0.76
Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group. Am J Cardiol (2000) 0.76
Epidemiology of acute hepatitis in the Stann Creek District of Belize, Central America. Am J Trop Med Hyg (2001) 0.75
Costs of coronary restenosis (Lovastatin Restenosis Trial). Am J Cardiol (1996) 0.75
Performance standards and edge detection with computerized quantitative coronary arteriography. The Lovastatin Restenosis Trial Group. Am J Cardiol (1996) 0.75
Relation of lumen size to restenosis after percutaneous transluminal coronary balloon angioplasty. Lovastatin Restenosis Trial Group. Am J Cardiol (1996) 0.75
Alterations in sympathetic nervous system activity with intraoperative hypothermia during coronary artery bypass surgery. Chest (1989) 0.75
Household income losses associated with ischaemic heart disease for US employees. Pharmacoeconomics (2000) 0.75
Noninvasive and angiographic evaluation of coronary artery disease in patients with peripheral vascular disease. Am J Cardiol (1989) 0.75
Impact of managed care on obstetrician-gynecologists' practice: the providers' perspective. Womens Health Issues (2001) 0.75
Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat [tirofiban]] and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial. Am J Cardiol (1999) 0.75
Food handlers: a potential high risk group for hypercholesterolemia. Navy Med (1990) 0.75
Prevalence of hepatitis B virus among health care workers in Belize, Central America. Am J Trop Med Hyg (1995) 0.75
Hepatitis B virus, human immunodeficiency virus type-1, and syphilis among women attending prenatal clinics in Belize, Central America. Am J Trop Med Hyg (1997) 0.75
Pacemaker-induced sustained ventricular tachycardia. Am J Cardiol (1984) 0.75